<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE collection SYSTEM "BioC.dtd">
<collection><source>PMC</source><date>20210806</date><key>pmc.key</key><document><id>8326803</id><infon key="license">CC BY</infon><passage><infon key="article-id_doi">10.3389/fnagi.2021.690383</infon><infon key="article-id_pmc">8326803</infon><infon key="article-id_pmid">34349633</infon><infon key="elocation-id">690383</infon><infon key="kwd">COVID-19 long-hauler cognitive stressors Community Dwellers post-acute sequelae of SARS-CoV-2 infection</infon><infon key="license">This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</infon><infon key="name_0">surname:Frontera;given-names:Jennifer A.</infon><infon key="name_1">surname:Lewis;given-names:Ariane</infon><infon key="name_10">surname:Galetta;given-names:Steven L.</infon><infon key="name_2">surname:Melmed;given-names:Kara</infon><infon key="name_3">surname:Lin;given-names:Jessica</infon><infon key="name_4">surname:Kondziella;given-names:Daniel</infon><infon key="name_5">surname:Helbok;given-names:Raimund</infon><infon key="name_6">surname:Yaghi;given-names:Shadi</infon><infon key="name_7">surname:Meropol;given-names:Sharon</infon><infon key="name_8">surname:Wisniewski;given-names:Thomas</infon><infon key="name_9">surname:Balcer;given-names:Laura</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">13</infon><infon key="year">2021</infon><offset>0</offset><text>Prevalence and Predictors of Prolonged Cognitive and Psychological Symptoms Following COVID-19 in the United States</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>116</offset><text>Background/Objectives</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>138</offset><text>Little is known regarding the prevalence and predictors of prolonged cognitive and psychological symptoms of COVID-19 among community-dwellers. We aimed to quantitatively measure self-reported metrics of fatigue, cognitive dysfunction, anxiety, depression, and sleep and identify factors associated with these metrics among United States residents with or without COVID-19.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>512</offset><text>Methods</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>520</offset><text>We solicited 1000 adult United States residents for an online survey conducted February 3–5, 2021 utilizing a commercial crowdsourcing community research platform. The platform curates eligible participants to approximate United States demographics by age, sex, and race proportions. COVID-19 was diagnosed by laboratory testing and/or by exposure to a known positive contact with subsequent typical symptoms. Prolonged COVID-19 was self-reported and coded for those with symptoms ≥ 1 month following initial diagnosis. The primary outcomes were NIH PROMIS/Neuro-QoL short-form T-scores for fatigue, cognitive dysfunction, anxiety, depression, and sleep compared among those with prolonged COVID-19 symptoms, COVID-19 without prolonged symptoms and COVID-19 negative subjects. Multivariable backwards step-wise logistic regression models were constructed to predict abnormal Neuro-QoL metrics.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>1418</offset><text>Results</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>1426</offset><text>Among 999 respondents, the average age was 45 years (range 18–84), 49% were male, 76 (7.6%) had a history of COVID-19 and 19/76 (25%) COVID-19 positive participants reported prolonged symptoms lasting a median of 4 months (range 1–13). Prolonged COVID-19 participants were more often younger, female, Hispanic, and had a history of depression/mood/thought disorder (all P &lt; 0.05). They experienced significantly higher rates of unemployment and financial insecurity, and their symptoms created greater interference with work and household activities compared to other COVID-19 status groups (all P &lt; 0.05). After adjusting for demographics, past medical history and stressor covariates in multivariable logistic regression analysis, COVID-19 status was independently predictive of worse Neuro-QoL cognitive dysfunction scores (adjusted OR 11.52, 95% CI 1.01–2.28, P = 0.047), but there were no significant differences in quantitative measures of anxiety, depression, fatigue, or sleep.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>2418</offset><text>Conclusion</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>2429</offset><text>Prolonged symptoms occurred in 25% of COVID-19 positive participants, and NeuroQoL cognitive dysfunction scores were significantly worse among COVID-19 positive subjects, even after accounting for demographic and stressor covariates. Fatigue, anxiety, depression, and sleep scores did not differ between COVID-19 positive and negative respondents.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>2777</offset><text>Introduction</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2790</offset><text>Prolonged symptoms of COVID-19 including fatigue, cognitive abnormalities and mood disorders have been reported, however, the prevalence of these symptoms in the general population is not known. Furthermore, community members without COVID-19 may suffer similar symptoms related to social and economic stressors encountered during the global pandemic. Qualitative reports of COVID-19-related symptoms are limited in their ability to assess the severity of physical and psychological manifestations. Self-reported health status batteries that have been validated in clinical and reference populations provide quantitative measures of symptoms and may help parse the impact of SARS-CoV-2 infection from pandemic-related stressors.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3519</offset><text>We aimed to estimate the prevalence of symptoms of anxiety, depression, fatigue, sleep abnormalities, and subjective cognitive dysfunction among United States residents with or without the diagnosis of COVID-19 using quantitative NIH PROMIS/Neuro-QoL metrics.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>3779</offset><text>Materials and Methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>3801</offset><text>Design and Participants</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>3825</offset><text>We surveyed an unprimed sample of adult (≥18 years old) community-dwelling United States residents between February 3–5, 2021, utilizing the online platform Prolific.co1. Prolific.co, which is compliant with European Union General Data Protection Regulations (GDPR), is a crowdsourcing platform developed to recruit human subjects for research purposes. Data quality, participant diversity and honesty of responses compare favorably with other similar crowdsourcing/micro-jobbing platforms. Prolific has approximately 148,000 participants representing all 50 US states that routinely participate in community research surveys. The site has security checks to ensure that bots are not infiltrating the site. Potential survey participants were presented with a generic survey title (“Prevalence of Medical Conditions among Community Dwellers”) to avoid influencing survey participation. Survey questions specifically pertaining to COVID-19 status and prolonged COVID-19 symptoms or “long-hauler” syndrome were placed at the end of the survey to avoid confounding of responses to Neuro-QoL metrics (Supplementary Table 1). All Neuro-QoL batteries inquired about self-reported health within the “past 7 days”. A representative respondent sample reflecting age, sex and race proportions in the United States population was automatically curated by the survey platform utilizing United States Census Bureau data with a target of 1,000 responses (Table 1). Regions of the United States were defined according to United States Census Bureau standards (Northeast, Midwest, South, and West), and population centers were characterized as rural, suburban, or urban.</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>5495</offset><text>Demographics of survey respondents (N = 999) compared to United States census data from 2020*.</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot; cellspacing=&quot;5&quot; cellpadding=&quot;5&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Survey respondents&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;United States census data&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Age (years) – median, 95% CI&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;45(95%&lt;italic&gt;CI&lt;/italic&gt;44−46)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;39&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Sex (male),%, 95% CI&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;490/999(49%,95%&lt;italic&gt;CI&lt;/italic&gt;46−52%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;162,478,564/328,239,523 (49.5%)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;Race&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;White, &lt;italic&gt;N&lt;/italic&gt; (%, 95% CI)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;765/999(77%,95%&lt;italic&gt;CI&lt;/italic&gt;74−79%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;236,332,457/328,239,523 (72%)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Black, &lt;italic&gt;N&lt;/italic&gt; (%, 95% CI)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;130/999(13%,95%&lt;italic&gt;CI&lt;/italic&gt;11−15%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;42,014,659/328,239,523 (12.8%)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Asian, &lt;italic&gt;N&lt;/italic&gt; (%, 95% CI)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;68/999(7%,95%&lt;italic&gt;CI&lt;/italic&gt;5−9%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;18,709,653/328,239,523 (5.7%)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;American Indian and Alaska Native, &lt;italic&gt;N&lt;/italic&gt; (%, 95% CI)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4/999(0.4%,95%&lt;italic&gt;CI&lt;/italic&gt;0.1−1%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;29,541,557/328,239,523 (0.9%)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Native Hawaiian/Pacific Islander, &lt;italic&gt;N&lt;/italic&gt; (%, 95% CI)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2/999(0.2%,95%&lt;italic&gt;CI&lt;/italic&gt;0.02−0.7%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;656,479/328,239,523 (0.2%)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Other or mixed race, &lt;italic&gt;N&lt;/italic&gt; (%, 95% CI)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;26/999(3%,95%&lt;italic&gt;CI&lt;/italic&gt;2−4%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;27,572,120/328,239,523 (8.4%)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Hispanic ethnicity, &lt;italic&gt;N&lt;/italic&gt; (%, 95% CI)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;47/999(5%,95%&lt;italic&gt;CI&lt;/italic&gt;4−6%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;60,396,072/328,239,523 (18.4%)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;Population by United States Regions&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Northeast, &lt;italic&gt;N&lt;/italic&gt; (%, 95% CI)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;197/999(20%,95%&lt;italic&gt;CI&lt;/italic&gt;17−22%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;17.1%, 95% CI&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Midwest, &lt;italic&gt;N&lt;/italic&gt; (%, 95% CI)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;209/999(21%,95%&lt;italic&gt;CI&lt;/italic&gt;18−24%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;20.8%, 95% CI&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;South, &lt;italic&gt;N&lt;/italic&gt; (%, 95% CI)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;413/999(41%,95%&lt;italic&gt;CI&lt;/italic&gt;38−44%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;38.3%, 95% CI&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;West, &lt;italic&gt;N&lt;/italic&gt; (%, 95% CI)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;180/999(18%,95%&lt;italic&gt;CI&lt;/italic&gt;16−21%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;23.9%, 95% CI&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>5590</offset><text>	Survey respondents	United States census data	 	Age (years) – median, 95% CI	45(95%CI44−46)	39	 	Sex (male),%, 95% CI	490/999(49%,95%CI46−52%)	162,478,564/328,239,523 (49.5%)	 	Race			 	White, N (%, 95% CI)	765/999(77%,95%CI74−79%)	236,332,457/328,239,523 (72%)	 	Black, N (%, 95% CI)	130/999(13%,95%CI11−15%)	42,014,659/328,239,523 (12.8%)	 	Asian, N (%, 95% CI)	68/999(7%,95%CI5−9%)	18,709,653/328,239,523 (5.7%)	 	American Indian and Alaska Native, N (%, 95% CI)	4/999(0.4%,95%CI0.1−1%)	29,541,557/328,239,523 (0.9%)	 	Native Hawaiian/Pacific Islander, N (%, 95% CI)	2/999(0.2%,95%CI0.02−0.7%)	656,479/328,239,523 (0.2%)	 	Other or mixed race, N (%, 95% CI)	26/999(3%,95%CI2−4%)	27,572,120/328,239,523 (8.4%)	 	Hispanic ethnicity, N (%, 95% CI)	47/999(5%,95%CI4−6%)	60,396,072/328,239,523 (18.4%)	 	Population by United States Regions			 	Northeast, N (%, 95% CI)	197/999(20%,95%CI17−22%)	17.1%, 95% CI	 	Midwest, N (%, 95% CI)	209/999(21%,95%CI18−24%)	20.8%, 95% CI	 	South, N (%, 95% CI)	413/999(41%,95%CI38−44%)	38.3%, 95% CI	 	West, N (%, 95% CI)	180/999(18%,95%CI16−21%)	23.9%, 95% CI	 	</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>6714</offset><text>Exposure</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>6723</offset><text>A diagnosis of COVID-19 was coded for subjects that had self-reported positive SARS-CoV-2 RT-PCR or antibody testing or for those that had exposure to a person with SARS-CoV-2 infection and subsequent symptoms of COVID-19 including fever &gt; 99.5F, new onset cough, shortness of breath, muscle pain, headache, sore throat and/or loss of taste/smell. “Prolonged COVID-19” was self-reported among COVID-19 participants who continued to have symptoms ≥1 month after initial diagnosis. COVID-19 status was trichotomized as negative, positive without prolonged symptoms and positive with prolonged symptoms. Symptom lists were developed from Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO) post-COVID questionnaires.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>7476</offset><text>Outcome Measures</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>7493</offset><text>The primary outcomes were the NIH/NINDS PROMIS Quality of Life in Neurological Disorders (NeuroQoL) short form self-reported health measures of anxiety, depression, fatigue, cognition and sleep. Neuro-QoL raw scores were converted into T-scores with a mean of 50 and standard deviation of 10 in a reference population (United States general population or clinical sample). Higher T-scores indicate worse self-reported health for the anxiety, depression, fatigue, and sleep metrics, while lower scores indicate worse self-reported health for the cognitive function metric.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>8065</offset><text>Statistical Analyses</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>8086</offset><text>This study was powered to detect a T-score mean difference of five points between COVID-19 positive and negative subjects (based on the average conditional minimal detectable change for Neuro-QoL anxiety and depression T-scores), assuming a United States COVID-19 positivity rate of 4%, power of 0.80, alpha of 0.05, and sample size of 820 participants. Patients were coded as having a worse than average NeuroQoL metric if their T-score was &gt;55 (for anxiety, depression, fatigue, or sleep), or &lt;45 (for cognition) based on data from reference populations (where mean T-score is set at 50 and the average minimal clinically significant difference in scores is 5).</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>8750</offset><text>Demographics, past medical history, stressors and new or worsened symptoms within the past month and NeuroQoL T-scores were compared between COVID-19 status groups using Chi-squared, Fisher’s Exact and Kruskal–Wallis non-parametric tests, as appropriate. Backwards step-wise, multivariable logistic regression models were constructed to predict worse than average Neuro-QoL scores (dichotomized at T-score &gt;55 for anxiety, depression, fatigue or sleep and &lt;45 for cognition) using the following covariates: age, race, ethnicity, sex, years of education, region of United States, population center (urban, suburban, and rural), COVID-19 status (negative, prolonged, positive but not prolonged), history of lung disease, history of depression/mood/thought disorder, and individual stressors within the last month (social isolation, financial insecurity, unemployment, food insecurity, homelessness, death of family member/friend, illness of family member/friend, fear of illness, new disability, education disruption, increased caregiver responsibilities, lack of access to childcare, political conflict with family/friends/colleagues, relationship issues with household, and domestic abuse/violence). This study was deemed IRB exempt per the NYU Langone Hospitals IRB. All analyses were conducted using IBM SPSS Statistics for Windows version 25 (IBM Corp., Armonk, NY, United States).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>10139</offset><text>Results</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>10147</offset><text>Of 1,000 responses, 999 were included in analysis and one duplicate was removed. Data were complete in 99.7% of responses. The average age was 45 years (range 18–84), 49% were male, and 77% were white. Respondents closely approximated United States census statistics for age, gender, race and region of United States, however, fewer Hispanics participated in this survey than are represented in the general United States population (Table 1). Overall, 76/999 (7.6%, 95% CI 6.0–9.4%) reported having COVID-19, either diagnosed by laboratory test (N = 46/76, 61%, 95% CI 49–72%) or by exposure to a known COVID-19 contact followed by typical symptoms (N = 30/76, 39%, 95% CI 28–51%). There were no statistically significant differences in demographics between patients who were diagnosed by laboratory or symptom-based criteria (Supplementary Table 2), however, those with symptom-based diagnoses tended to have COVID earlier in the pandemic, were more often from urban areas and were more often from the Northeast. This may reflect the limited COVID-19 testing that was available during the beginning of the pandemic in New York City region. No respondents were hospitalized for COVID-19. Of those with reported COVID-19, 19/76 (25%, 95% CI 16–36%) reported prolonged COVID-19 symptoms lasting a median of 4 months (range 1–13). Of these 19, 13 (68%) had laboratory confirmation and 6 (32%) had a COVID-19 exposure followed by typical symptoms. At least one stressor was identified in 676/999 (68%, 95% CI 65–71%) subjects within the last month and 648/999 (65%, 95% CI 62–68%) reported at least one new/worsened symptom since the onset of the pandemic. Overall, worse than average Neuro-QOL scores for anxiety, depression, fatigue, cognition and sleep occurred in 335/999 (34%, 95% CI 31–37%), 220/999 (22%, 95% CI 19–25%), 164/999 (16%, 95% CI 14–19%), 313/999 (31%, 95% CI 29–34%), and 279/999 (28%, 95% CI 25–31%), respectively.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>12105</offset><text>Comparing respondents with a history of COVID-19 to those without, those with COVID were younger, more often Hispanic, and more often had a history of lung disease (Table 2). COVID-19 respondents had a significantly higher number of symptoms, specifically brain fog, headache, shortness of breath, cough, wheezing, chest pain, irregular heartbeat, fatigue, post-exertional malaise/brain fog, persistent loss of taste/smell, fever, dizziness/lightheadedness, and anxiety (Figure 1). These symptoms were more likely to interfere with work or household responsibilities compared to COVID negative respondents. COVID-19 respondents also had significantly higher rates of financial insecurity, domestic violence/abuse, or relationship problems with members of their household, though the total number of stressors experienced did not differ between COVID positive and negative groups (Figure 2).</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>12996</offset><text>Characteristics of survey participants (N = 999).</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot; cellspacing=&quot;5&quot; cellpadding=&quot;5&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Prolonged COVID-19 symptoms&lt;sup&gt;#&lt;/sup&gt;
&lt;italic&gt;N&lt;/italic&gt; = 19&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;COVID-19 positive&lt;sup&gt;∧&lt;/sup&gt; without prolonged symptoms &lt;italic&gt;N&lt;/italic&gt; = 57&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;COVID-19 negative &lt;italic&gt;N&lt;/italic&gt; = 923&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;italic&gt;P&lt;/italic&gt;*&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;italic&gt;P&lt;/italic&gt;&lt;sup&gt;¶&lt;/sup&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;Demographics&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Age, median (IQR)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;32 (22–51)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;44 (28–56)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;45 (31–60)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;0.010&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;0.013&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Sex (male), &lt;italic&gt;N&lt;/italic&gt; (%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;6 (32%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;37 (65%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;447 (48%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;0.017&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.172&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Race, &lt;italic&gt;N&lt;/italic&gt; (%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;0.039&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.283&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;White&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;13 (68%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;50 (88%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;702 (76%)&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Black&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3 (16%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7 (12%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;120 (13%)&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Asian&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;68 (7%)&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Native American/Alaskan Native&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4 (0.4%)&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Pacific Islander/Native Hawaiian&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2 (0.2%)&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Other&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3 (16%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;23 (3%)&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Unknown/prefer not to answer&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4 (0.4%)&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ethnicity, &lt;italic&gt;N&lt;/italic&gt; (%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;&amp;lt;0.001&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;0.023&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Hispanic&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5 (26%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3 (5%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;39 (4%)&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Non-Hispanic&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;14 (74%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;54 (95%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;868 (96%)&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Years of education, median (IQR)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;15 (14–16)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;16 (14–18)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;16 (14–17)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.265&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.928&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Region of United States&lt;sup&gt;∗∗&lt;/sup&gt;, &lt;italic&gt;N&lt;/italic&gt; (%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.276&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.102&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;North East&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4 (21%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;10 (18%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;183 (20%)&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Mid-West&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2 (11%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;13 (23%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;194 (21%)&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;South&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;11 (58%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;29 (51%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;373 (40%)&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;West&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2 (11%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5 (9%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;173 (19%)&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Population center, &lt;italic&gt;N&lt;/italic&gt; (%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.310&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.179&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Urban&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;10 (53%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;20 (35%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;263 (29%)&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Suburban&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;8 (42%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;30 (53%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;506 (55%)&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Rural&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1 (5%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7 (12%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;152 (17%)&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Time from COVID diagnosis to survey, median (IQR)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4 months (2–9 months)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2 months (&amp;lt;1–6 months)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;–&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.255&lt;sup&gt;Υ&lt;/sup&gt;&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;Past medical history, &lt;italic&gt;N&lt;/italic&gt; (%)&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;None&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;13 (68%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;32 (56%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;532 (58%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.621&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.790&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Hypertension&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3 (16%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;14 (25%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;243 (26%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.565&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.499&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Diabetes&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1 (5%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4 (7%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;100 (11%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.497&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.330&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Coronary artery disease&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1 (5%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;24 (3%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.351&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.00&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Peripheral artery disease&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1 (5%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;8 (1%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.101&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.511&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Arrhythmia&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1 (5%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3 (5%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;26 (3%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.486&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.278&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Lung disease (COPD/asthma)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2 (11%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;8 (14%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;50 (5%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;0.021&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;0.019&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cancer&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1 (5%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;6 (11%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;44 (5%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.159&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.101&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Venous thromboembolism&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;14 (2%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.557&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.617&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Chronic liver disease&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4 (0.4%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.848&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.00&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Chronic kidney disease&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1 (5%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1 (2%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;11 (1%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.287&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.260&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Anemia&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3 (16%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5 (9%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;61 (7%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.251&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.233&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;Neurological/psychiatric history, &lt;italic&gt;N&lt;/italic&gt; (%)&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;None&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;6 (32%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;33 (58%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;535 (58%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.070&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.260&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Stroke&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1 (5%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1 (2%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;8 (1%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.137&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.173&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Head trauma&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1 (2%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;23 (3%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.740&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.00&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Seizure/epilepsy&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1 (2%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;11 (1%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.828&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.00&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Dementia&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;—&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;—&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Fibromyalgia&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2 (11%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1 (2%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;30 (3%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.170&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.734&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Chronic fatigue syndrome&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;—&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;—&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Depression&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;11 (58%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;17 (30%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;252 (27%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;0.013&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.075&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Anxiety&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;8 (42%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;18 (32%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;283 (31%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.562&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.520&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Other mood disorder (e.g., bipolar)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5 (26%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1 (2%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;47 (5%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;&amp;lt;0.001&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.284&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Thought disorder&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1 (5%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4 (0.4%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;0.011&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.327&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;Stressors in the last month, &lt;italic&gt;N&lt;/italic&gt; (%)&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Total number, median (IQR)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3 (1–5)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2 (0–4)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1 (0–3)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.083&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.076&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;None&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4 (21%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;19 (33%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;306 (33%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.538&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.606&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Social isolation&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7 (37%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;15 (26%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;323 (35%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.400&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.287&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Unemployment&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;6 (32%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;6 (11%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;110 (12%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;0.032&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.322&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Financial insecurity&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;10 (53%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;17 (30%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;225 (24%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;0.014&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;0.031&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Homelessness&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;54 (5%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;15 (2%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.112&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.143&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Food insecurity&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1 (5%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4 (7%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;39 (4%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.598&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.336&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Death of family member/friend&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3 (16%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;6 (11%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;89 (10%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.660&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.546&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Illness of family member/friend&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4 (21%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;15 (26%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;160 (17%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.215&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.118&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Fear of illness&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7 (37%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;15 (26%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;252 (27%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.641&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.757&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Domestic abuse/violence&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1 (5%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4 (7%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;12 (1%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;0.003&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;0.007&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Relationship problems in household&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3 (16%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;13 (23%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;108 (12%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;0.043&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;0.028&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;New disability&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;—&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;—&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Lack of access to childcare&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4 (7%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;24 (3%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.111&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.158&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Increased caregiver responsibilities&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4 (21%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;6 (11%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;84 (9%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.201&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.244&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Education disruption&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5 (9%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;72 (8%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.430&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.00&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Political conflict with family/friends&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7 (37%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;11 (19%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;140 (15%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;0.028&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.070&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;Qualitative Symptoms in the last month, &lt;italic&gt;N&lt;/italic&gt; (%)&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Total number, median (IQR)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;6 (2–9)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2 (0–7)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1 (0–4)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;&amp;lt;0.001&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;&amp;lt;0.001&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;None&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1 (5%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;17 (32%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;371 (41%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;0.004&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;0.009&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Brain fog, difficulty concentrating, forgetfulness&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;9 (47%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;16 (28%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;205 (22%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;0.023&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;0.033&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Post-exertional brain fog&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;8 (42%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;6 (11%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;57 (6%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;&amp;lt;0.001&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;&amp;lt;0.001&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Headache&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;9 (47%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;20 (35%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;201 (22%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;0.003&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;0.001&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cough&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3 (16%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;13 (23%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;64 (7%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;&amp;lt;0.001&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;&amp;lt;0.001&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Vision abnormalities&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5 (26%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4 (7%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;69 (8%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;0.010&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.180&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Shortness of breath&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5 (26%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;10 (18%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;62 (7%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;&amp;lt;0.001&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;&amp;lt;0.001&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Wheezing&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4 (21%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5 (9%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;25 (3%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;&amp;lt;0.001&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;&amp;lt;0.001&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Irregular heart beat&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4 (21%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;8 (14%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;49 (5%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;0.001&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;0.001&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Chest pain&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7 (37%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7 (12%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;34 (4%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;&amp;lt;0.001&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;&amp;lt;0.001&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Fatigue&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;8 (42%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;21 (37%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;246 (27%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.088&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;0.031&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Post-exertional malaise/fatigue&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5 (26%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;8 (14%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;55 (6%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;&amp;lt;0.001&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;0.001&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Joint pain&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7 (37%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;12 (21%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;150 (16%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;0.042&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.056&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Muscle pain/aches&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7 (37%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;15 (26%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;182 (20%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.098&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.055&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Difficulty sleeping&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;6 (32%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;18 (32%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;269 (29%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.904&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.654&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Persistent loss taste/smell&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4 (21%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;8 (14%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;11 (1%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;&amp;lt;0.001&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;&amp;lt;0.001&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Fever&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2 (11%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;8 (14%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;16 (2%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;&amp;lt;0.001&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;&amp;lt;0.001&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Dizziness/lightheadedness&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5 (26%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;6 (11%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;49 (5%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;&amp;lt;0.001&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;0.004&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Anxiety&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;10 (53%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;21 (37%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;258 (28%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;0.025&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;0.018&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Depression&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;8 (42%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;15 (26%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;243 (26%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.305&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.456&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;Impact due to symptoms, &lt;italic&gt;N&lt;/italic&gt; (%)&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;No limitations on activities&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1 (5%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;24 (42%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;468 (51%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;&amp;lt;0.001&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;0.003&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Interfering with work&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;10 (53%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;21 (37%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;163 (18%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;&amp;lt;0.001&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;&amp;lt;0.001&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Interfering with household responsibilities&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;13 (68%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;21 (37%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;239 (26%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;&amp;lt;0.001&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;&amp;lt;0.001&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Limiting leisure activities&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;12 (63%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;21 (37%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;229 (63%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;&amp;lt;0.001&lt;/bold&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;bold&gt;&amp;lt;0.001&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>13046</offset><text>	Prolonged COVID-19 symptoms#N = 19	COVID-19 positive∧ without prolonged symptoms N = 57	COVID-19 negative N = 923	P*	P¶	 	Demographics						 	Age, median (IQR)	32 (22–51)	44 (28–56)	45 (31–60)	0.010	0.013	 	Sex (male), N (%)	6 (32%)	37 (65%)	447 (48%)	0.017	0.172	 	Race, N (%)				0.039	0.283	 	White	13 (68%)	50 (88%)	702 (76%)			 	Black	3 (16%)	7 (12%)	120 (13%)			 	Asian	0	0	68 (7%)			 	Native American/Alaskan Native	0	0	4 (0.4%)			 	Pacific Islander/Native Hawaiian	0	0	2 (0.2%)			 	Other	3 (16%)	0	23 (3%)			 	Unknown/prefer not to answer	0	0	4 (0.4%)			 	Ethnicity, N (%)				&lt;0.001	0.023	 	Hispanic	5 (26%)	3 (5%)	39 (4%)			 	Non-Hispanic	14 (74%)	54 (95%)	868 (96%)			 	Years of education, median (IQR)	15 (14–16)	16 (14–18)	16 (14–17)	0.265	0.928	 	Region of United States∗∗, N (%)				0.276	0.102	 	North East	4 (21%)	10 (18%)	183 (20%)			 	Mid-West	2 (11%)	13 (23%)	194 (21%)			 	South	11 (58%)	29 (51%)	373 (40%)			 	West	2 (11%)	5 (9%)	173 (19%)			 	Population center, N (%)				0.310	0.179	 	Urban	10 (53%)	20 (35%)	263 (29%)			 	Suburban	8 (42%)	30 (53%)	506 (55%)			 	Rural	1 (5%)	7 (12%)	152 (17%)			 	Time from COVID diagnosis to survey, median (IQR)	4 months (2–9 months)	2 months (&lt;1–6 months)	–	0.255Υ		 	Past medical history, N (%)						 	None	13 (68%)	32 (56%)	532 (58%)	0.621	0.790	 	Hypertension	3 (16%)	14 (25%)	243 (26%)	0.565	0.499	 	Diabetes	1 (5%)	4 (7%)	100 (11%)	0.497	0.330	 	Coronary artery disease	1 (5%)	0	24 (3%)	0.351	1.00	 	Peripheral artery disease	1 (5%)	0	8 (1%)	0.101	0.511	 	Arrhythmia	1 (5%)	3 (5%)	26 (3%)	0.486	0.278	 	Lung disease (COPD/asthma)	2 (11%)	8 (14%)	50 (5%)	0.021	0.019	 	Cancer	1 (5%)	6 (11%)	44 (5%)	0.159	0.101	 	Venous thromboembolism	0	0	14 (2%)	0.557	0.617	 	Chronic liver disease	0	0	4 (0.4%)	0.848	1.00	 	Chronic kidney disease	1 (5%)	1 (2%)	11 (1%)	0.287	0.260	 	Anemia	3 (16%)	5 (9%)	61 (7%)	0.251	0.233	 	Neurological/psychiatric history, N (%)						 	None	6 (32%)	33 (58%)	535 (58%)	0.070	0.260	 	Stroke	1 (5%)	1 (2%)	8 (1%)	0.137	0.173	 	Head trauma	0	1 (2%)	23 (3%)	0.740	1.00	 	Seizure/epilepsy	0	1 (2%)	11 (1%)	0.828	1.00	 	Dementia	0	0	0	—	—	 	Fibromyalgia	2 (11%)	1 (2%)	30 (3%)	0.170	0.734	 	Chronic fatigue syndrome	0	0	0	—	—	 	Depression	11 (58%)	17 (30%)	252 (27%)	0.013	0.075	 	Anxiety	8 (42%)	18 (32%)	283 (31%)	0.562	0.520	 	Other mood disorder (e.g., bipolar)	5 (26%)	1 (2%)	47 (5%)	&lt;0.001	0.284	 	Thought disorder	1 (5%)	0	4 (0.4%)	0.011	0.327	 	Stressors in the last month, N (%)						 	Total number, median (IQR)	3 (1–5)	2 (0–4)	1 (0–3)	0.083	0.076	 	None	4 (21%)	19 (33%)	306 (33%)	0.538	0.606	 	Social isolation	7 (37%)	15 (26%)	323 (35%)	0.400	0.287	 	Unemployment	6 (32%)	6 (11%)	110 (12%)	0.032	0.322	 	Financial insecurity	10 (53%)	17 (30%)	225 (24%)	0.014	0.031	 	Homelessness	0	54 (5%)	15 (2%)	0.112	0.143	 	Food insecurity	1 (5%)	4 (7%)	39 (4%)	0.598	0.336	 	Death of family member/friend	3 (16%)	6 (11%)	89 (10%)	0.660	0.546	 	Illness of family member/friend	4 (21%)	15 (26%)	160 (17%)	0.215	0.118	 	Fear of illness	7 (37%)	15 (26%)	252 (27%)	0.641	0.757	 	Domestic abuse/violence	1 (5%)	4 (7%)	12 (1%)	0.003	0.007	 	Relationship problems in household	3 (16%)	13 (23%)	108 (12%)	0.043	0.028	 	New disability	0	0	0	—	—	 	Lack of access to childcare	0	4 (7%)	24 (3%)	0.111	0.158	 	Increased caregiver responsibilities	4 (21%)	6 (11%)	84 (9%)	0.201	0.244	 	Education disruption	0	5 (9%)	72 (8%)	0.430	1.00	 	Political conflict with family/friends	7 (37%)	11 (19%)	140 (15%)	0.028	0.070	 	Qualitative Symptoms in the last month, N (%)						 	Total number, median (IQR)	6 (2–9)	2 (0–7)	1 (0–4)	&lt;0.001	&lt;0.001	 	None	1 (5%)	17 (32%)	371 (41%)	0.004	0.009	 	Brain fog, difficulty concentrating, forgetfulness	9 (47%)	16 (28%)	205 (22%)	0.023	0.033	 	Post-exertional brain fog	8 (42%)	6 (11%)	57 (6%)	&lt;0.001	&lt;0.001	 	Headache	9 (47%)	20 (35%)	201 (22%)	0.003	0.001	 	Cough	3 (16%)	13 (23%)	64 (7%)	&lt;0.001	&lt;0.001	 	Vision abnormalities	5 (26%)	4 (7%)	69 (8%)	0.010	0.180	 	Shortness of breath	5 (26%)	10 (18%)	62 (7%)	&lt;0.001	&lt;0.001	 	Wheezing	4 (21%)	5 (9%)	25 (3%)	&lt;0.001	&lt;0.001	 	Irregular heart beat	4 (21%)	8 (14%)	49 (5%)	0.001	0.001	 	Chest pain	7 (37%)	7 (12%)	34 (4%)	&lt;0.001	&lt;0.001	 	Fatigue	8 (42%)	21 (37%)	246 (27%)	0.088	0.031	 	Post-exertional malaise/fatigue	5 (26%)	8 (14%)	55 (6%)	&lt;0.001	0.001	 	Joint pain	7 (37%)	12 (21%)	150 (16%)	0.042	0.056	 	Muscle pain/aches	7 (37%)	15 (26%)	182 (20%)	0.098	0.055	 	Difficulty sleeping	6 (32%)	18 (32%)	269 (29%)	0.904	0.654	 	Persistent loss taste/smell	4 (21%)	8 (14%)	11 (1%)	&lt;0.001	&lt;0.001	 	Fever	2 (11%)	8 (14%)	16 (2%)	&lt;0.001	&lt;0.001	 	Dizziness/lightheadedness	5 (26%)	6 (11%)	49 (5%)	&lt;0.001	0.004	 	Anxiety	10 (53%)	21 (37%)	258 (28%)	0.025	0.018	 	Depression	8 (42%)	15 (26%)	243 (26%)	0.305	0.456	 	Impact due to symptoms, N (%)						 	No limitations on activities	1 (5%)	24 (42%)	468 (51%)	&lt;0.001	0.003	 	Interfering with work	10 (53%)	21 (37%)	163 (18%)	&lt;0.001	&lt;0.001	 	Interfering with household responsibilities	13 (68%)	21 (37%)	239 (26%)	&lt;0.001	&lt;0.001	 	Limiting leisure activities	12 (63%)	21 (37%)	229 (63%)	&lt;0.001	&lt;0.001	 	</text></passage><passage><infon key="file">fnagi-13-690383-g001.jpg</infon><infon key="id">F1</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>18183</offset><text>Symptoms in the month prior to interview in subjects with prolonged COVID-19 symptoms, COVID-19 without prolonged symptoms and COVID-19 negative subjects. *P &lt; 0.05 comparing across all three groups; #P &lt; 0.05 comparing COVID positive to COVID negative.</text></passage><passage><infon key="file">fnagi-13-690383-g002.jpg</infon><infon key="id">F2</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>18437</offset><text>Socio-economic stressors in the month prior to interview in subjects with prolonged COVID-19 symptoms, COVID-19 without prolonged symptoms and COVID-19 negative subjects. *P &lt; 0.05 comparing across all three groups; #P &lt; 0.05 comparing COVID positive to COVID negative.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>18707</offset><text>Participants with prolonged COVID-19 symptoms were more often younger, female, Hispanic, and had a history of depression, mood or thought disorder (Table 2). Stressors including unemployment, financial insecurity and political conflict were also more common in this group (Figure 2). The most common symptoms in the prolonged COVID-19 group were anxiety (53%), brain fog/difficulty concentrating/forgetfulness (47%), and headache (47%). This group experienced a greater number of symptoms in the prior month and were more disabled by these symptoms (symptoms interfered with work, household, or leisure activities) compared to other non-prolonged and COVID-19 negative respondents (Figure 3).</text></passage><passage><infon key="file">fnagi-13-690383-g003.jpg</infon><infon key="id">F3</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>19400</offset><text>Abnormal NeuroQoL T-scores in subjects with prolonged COVID-19 symptoms, COVID-19 without prolonged symptoms and COVID-19 negative subjects. Abnormal T-scores were defined as: T-score &gt; 55 for anxiety, depression, fatigue, or sleep and &lt;45 for cognition. *P &lt; 0.05 comparing across all three groups; #P &lt; 0.05 comparing COVID positive to COVID negative.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>19754</offset><text>In univariate analyses, COVID-19 positive subjects (including those with and without prolonged symptoms) had significantly worse subjective measures of cognitive function than COVID-19 negative respondents, though NeuroQoL measures of fatigue, anxiety, depression and sleep symptoms did not differ between groups. Those with prolonged COVID-19 had significantly worse NeuroQoL T-scores and higher rates of worse than average symptoms of anxiety, cognition, fatigue and sleep than other groups (Table 3). After adjusting for demographic, past medical history and stressor covariates in multivariable logistic regression analysis, COVID-19 status (prolonged vs. not-prolonged vs. negative) was independently associated with worse Neuro-QoL cognitive dysfunction scores (adjusted OR 1.52, 95% CI 1.01–2.28, P = 0.047, Table 4), but there were no significant differences in quantitative measures of anxiety, depression, fatigue, or sleep. The most consistent factors significantly associated with worse NeuroQoL metrics across a variety of domains were: younger age, female gender, history of depression, social isolation, and relationship problems with members of the household (Table 4).</text></passage><passage><infon key="file">T3.xml</infon><infon key="id">T3</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>20942</offset><text>Neuro-QoL T-scores by COVID-status (N = 999).</text></passage><passage><infon key="file">T3.xml</infon><infon key="id">T3</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot; cellspacing=&quot;5&quot; cellpadding=&quot;5&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Metric&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Prolonged COVID-19 symptoms &lt;italic&gt;N&lt;/italic&gt; = 19&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;COVID-19 without prolonged symptoms &lt;italic&gt;N&lt;/italic&gt; = 57&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;COVID-19 negative &lt;italic&gt;N&lt;/italic&gt; = 923&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;italic&gt;P&lt;/italic&gt;*&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;italic&gt;P&lt;/italic&gt;&lt;sup&gt;¶&lt;/sup&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Anxiety T-score, median (IQR) Anxiety T-score &amp;gt; 55, &lt;italic&gt;N&lt;/italic&gt; (%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;56.8 (51.4–62.6) 12/19 (63%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;53.3 (45.1–56.8) 18/57 (32%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;51.4 (45.9–57.6) 305/923 (33%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.007&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.201&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Depression T-score, median (IQR) Depression T-score &amp;gt; 55&lt;sup&gt;∧&lt;/sup&gt;, &lt;italic&gt;N&lt;/italic&gt; (%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;51.3 (46.8–56.7) 6/19 (32%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;46.8 (36.9–53.2) 9/57 (16%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;47.9 (43.1–53.6) 205/923 (22%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.113&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.834&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cognition T-score, median (IQR) Cognition T-score &amp;lt;45&lt;sup&gt;∧&lt;/sup&gt;, &lt;italic&gt;N&lt;/italic&gt; (%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;41.9 (38.9–48.3) 13/19 (68%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;47.1 (42.4–54.2) 20/57 (35%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;50.9 (43.9–59.0) 280/923 (30%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt;0.001&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Fatigue T-score, median (IQR) Fatigue T-score &amp;gt; 55&lt;sup&gt;∧&lt;/sup&gt;, &lt;italic&gt;N&lt;/italic&gt; (%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;54.4 (48.4–57.6) 8/19 (42%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;43.8 (40.7–50.8) 4/57 (7%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;45.6 (39.5–52.3) 152/922 (17%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.004&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.370&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Sleep T-score, median (IQR) Sleep T-score &amp;gt; 55&lt;sup&gt;∧&lt;/sup&gt;, &lt;italic&gt;N&lt;/italic&gt; (%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;58.0 (50.4–62.8) 12/19 (63%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;47.3 (42.8–53.1) 12/57 (21%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;48.9 (41.7–55.6) 255/922 (28%)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.004&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.432&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>20988</offset><text>Metric	Prolonged COVID-19 symptoms N = 19	COVID-19 without prolonged symptoms N = 57	COVID-19 negative N = 923	P*	P¶	 	Anxiety T-score, median (IQR) Anxiety T-score &gt; 55, N (%)	56.8 (51.4–62.6) 12/19 (63%)	53.3 (45.1–56.8) 18/57 (32%)	51.4 (45.9–57.6) 305/923 (33%)	0.007	0.201	 	Depression T-score, median (IQR) Depression T-score &gt; 55∧, N (%)	51.3 (46.8–56.7) 6/19 (32%)	46.8 (36.9–53.2) 9/57 (16%)	47.9 (43.1–53.6) 205/923 (22%)	0.113	0.834	 	Cognition T-score, median (IQR) Cognition T-score &lt;45∧, N (%)	41.9 (38.9–48.3) 13/19 (68%)	47.1 (42.4–54.2) 20/57 (35%)	50.9 (43.9–59.0) 280/923 (30%)	&lt;0.001	0.001	 	Fatigue T-score, median (IQR) Fatigue T-score &gt; 55∧, N (%)	54.4 (48.4–57.6) 8/19 (42%)	43.8 (40.7–50.8) 4/57 (7%)	45.6 (39.5–52.3) 152/922 (17%)	0.004	0.370	 	Sleep T-score, median (IQR) Sleep T-score &gt; 55∧, N (%)	58.0 (50.4–62.8) 12/19 (63%)	47.3 (42.8–53.1) 12/57 (21%)	48.9 (41.7–55.6) 255/922 (28%)	0.004	0.432	 	</text></passage><passage><infon key="file">T4.xml</infon><infon key="id">T4</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>21957</offset><text>Multivariable logistic regression models predicting worse than average Neuro-QoL metrics among subjects with prolonged COVID-19 symptoms (N = 19), COVID-19 without prolonged symptoms (N = 57), and COVID-19 negative (N = 923) subjects.</text></passage><passage><infon key="file">T4.xml</infon><infon key="id">T4</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot; cellspacing=&quot;5&quot; cellpadding=&quot;5&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Variable&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Adjusted Odds Ratio (95% CI)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;italic&gt;P&lt;/italic&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; colspan=&quot;3&quot; rowspan=&quot;1&quot;&gt;&lt;bold&gt;Neuro-QoL anxiety scores worse than average (T-score &amp;gt; 55)&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Age&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.96 (0.95–0.97)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt;0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Sex (male)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.71 (0.51–0.98)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.034&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Years of education&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.92 (0.86–0.98)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.009&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;History of depression/mood/thought disorder&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3.48 (2.49–4.88)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt;0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Social isolation&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.79 (1.27–2.53)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Relationship problem with member of household&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2.64 (1.63–4.27)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt;0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Fear of illness&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.98 (1.38–2.84)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt;0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; colspan=&quot;3&quot; rowspan=&quot;1&quot;&gt;&lt;bold&gt;Neuro-QoL depression scores worse than average (T-score &amp;gt; 55)&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Age&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.97 (0.96–0.98)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt;0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;History of depression/mood/thought disorder&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4.81 (3.38–6.84)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt;0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Social isolation&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.93 (1.35–2.67)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt;0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Unemployment&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.75 (1.10–2.80)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.012&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Relationship problem with member of household&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.70 (1.07–2.72)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.025&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; colspan=&quot;3&quot; rowspan=&quot;1&quot;&gt;&lt;bold&gt;Neuro-QoL fatigue scores worse than average (T-score &amp;gt; 55)&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Age&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.98 (0.97–0.99)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.002&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Sex (male)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.63 (0.43–0.93)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.021&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Years of education&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.89 (0.82–0.96)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.003&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;History of depression/mood/thought disorder&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3.35 (2.27–4.95)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt;0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;History of lung disease (asthma/COPD)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2.29 (1.16–4.50)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.017&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Social Isolation&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.69 (1.12–2.54)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.012&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Relationship problem with member of household&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2.35 (1.44–3.85)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Fear of illness&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.63 (1.07–2.47)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.022&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Political conflict with family/friends/colleagues&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.61 (1.02–2.56)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.043&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; colspan=&quot;3&quot; rowspan=&quot;1&quot;&gt;&lt;bold&gt;Neuro-QoL cognitive dysfunction scores worse than average (T-score &amp;lt;45)&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Age&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.97 (0.96–0.98)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt;0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Years of education&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.92 (0.86–0.98)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.007&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;History of depression/mood/thought disorder&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3.46 (2.49–4.79)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt;0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Social Isolation&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2.30 (1.66–3.19)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt;0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Food insecurity&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2.42 (1.15–5.07)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.020&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Illness of family member/friend&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.74 (1.18–2.57)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.005&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Political conflict with family/friends/colleagues&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.66 (1.10–2.51)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.016&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;COVID-19 status (negative, positive/no prolonged symptoms, positive with prolonged symptoms)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.52 (1.01–2.28)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.047&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;justify&quot; colspan=&quot;3&quot; rowspan=&quot;1&quot;&gt;&lt;bold&gt;Neuro-QoL sleep scores worse than average (T-score &amp;gt; 55)&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Age&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.98 (0.97–0.99)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt;0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Sex (male)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.60 (0.44–0.83)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.002&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Hispanic ethnicity&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2.25 (1.14–4.56)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.020&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;History of depression/mood/thought disorder&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3.24 (2.33–4.50)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt;0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Education disruption&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2.09 (1.21–3.61)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.008&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Social Isolation&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.74 (1.24–2.43)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Death of family member/friend&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.70 (1.04–2.81)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.036&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Food insecurity&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;3.07 (1.49–6.32)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.002&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Political conflict with family/friends/colleagues&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.86 (1.23–2.80)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;center&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.003&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>22192</offset><text>Variable	Adjusted Odds Ratio (95% CI)	P	 	Neuro-QoL anxiety scores worse than average (T-score &gt; 55)	 	Age	0.96 (0.95–0.97)	&lt;0.001	 	Sex (male)	0.71 (0.51–0.98)	0.034	 	Years of education	0.92 (0.86–0.98)	0.009	 	History of depression/mood/thought disorder	3.48 (2.49–4.88)	&lt;0.001	 	Social isolation	1.79 (1.27–2.53)	0.001	 	Relationship problem with member of household	2.64 (1.63–4.27)	&lt;0.001	 	Fear of illness	1.98 (1.38–2.84)	&lt;0.001	 	Neuro-QoL depression scores worse than average (T-score &gt; 55)	 	Age	0.97 (0.96–0.98)	&lt;0.001	 	History of depression/mood/thought disorder	4.81 (3.38–6.84)	&lt;0.001	 	Social isolation	1.93 (1.35–2.67)	&lt;0.001	 	Unemployment	1.75 (1.10–2.80)	0.012	 	Relationship problem with member of household	1.70 (1.07–2.72)	0.025	 	Neuro-QoL fatigue scores worse than average (T-score &gt; 55)	 	Age	0.98 (0.97–0.99)	0.002	 	Sex (male)	0.63 (0.43–0.93)	0.021	 	Years of education	0.89 (0.82–0.96)	0.003	 	History of depression/mood/thought disorder	3.35 (2.27–4.95)	&lt;0.001	 	History of lung disease (asthma/COPD)	2.29 (1.16–4.50)	0.017	 	Social Isolation	1.69 (1.12–2.54)	0.012	 	Relationship problem with member of household	2.35 (1.44–3.85)	0.001	 	Fear of illness	1.63 (1.07–2.47)	0.022	 	Political conflict with family/friends/colleagues	1.61 (1.02–2.56)	0.043	 	Neuro-QoL cognitive dysfunction scores worse than average (T-score &lt;45)	 	Age	0.97 (0.96–0.98)	&lt;0.001	 	Years of education	0.92 (0.86–0.98)	0.007	 	History of depression/mood/thought disorder	3.46 (2.49–4.79)	&lt;0.001	 	Social Isolation	2.30 (1.66–3.19)	&lt;0.001	 	Food insecurity	2.42 (1.15–5.07)	0.020	 	Illness of family member/friend	1.74 (1.18–2.57)	0.005	 	Political conflict with family/friends/colleagues	1.66 (1.10–2.51)	0.016	 	COVID-19 status (negative, positive/no prolonged symptoms, positive with prolonged symptoms)	1.52 (1.01–2.28)	0.047	 	Neuro-QoL sleep scores worse than average (T-score &gt; 55)	 	Age	0.98 (0.97–0.99)	&lt;0.001	 	Sex (male)	0.60 (0.44–0.83)	0.002	 	Hispanic ethnicity	2.25 (1.14–4.56)	0.020	 	History of depression/mood/thought disorder	3.24 (2.33–4.50)	&lt;0.001	 	Education disruption	2.09 (1.21–3.61)	0.008	 	Social Isolation	1.74 (1.24–2.43)	0.001	 	Death of family member/friend	1.70 (1.04–2.81)	0.036	 	Food insecurity	3.07 (1.49–6.32)	0.002	 	Political conflict with family/friends/colleagues	1.86 (1.23–2.80)	0.003	 	</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>24606</offset><text>We next explored the relationship of age with socio-economic stressors, symptoms and Neuro-QoL T-scores. Age was negatively correlated with both the number of symptoms (Spearman correlation coefficient −0.105, P = 0.001) and stressors (Spearman correlation coefficient −0.131, P &lt; 0.001) experienced by subjects in the month prior to the survey. Notably, unemployment (Spearman correlation coefficient −0.146, P &lt; 0.001) and financial insecurity (Spearman correlation coefficient −0.129, P &lt; 0.001) were most strongly associated with younger age. Additionally, older respondents were less likely to report limitations in their routine activities due to symptoms (OR 0.98, 95% CI 0.97–0.99, P &lt; 0.001). Overall, while age was inversely related to worse Neuro-QoL T-scores in multivariable analyses (Table 4), there was a suggestion of a bimodal distribution of worse T-scores for depression, cognition and sleep with peaks around ages 30 and again at 60–65 (Figure 4).</text></passage><passage><infon key="file">fnagi-13-690383-g004.jpg</infon><infon key="id">F4</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>25586</offset><text>Distribution of Neuro-QoL T-scores by age. There is a suggestion of a bimodal peak in worse depression, cognitive and sleep score with peaks around ages 30–35 and again around ages 60–65.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>25778</offset><text>Discussion</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>25789</offset><text>This study is the first, to our knowledge, to establish baseline quantitative measures of the prevalence of common symptoms of “long-hauler” syndrome – including cognitive dysfunction, fatigue, anxiety, depression, and sleep disorders – in a representative population of community-dwelling United States residents with and without a history of COVID-19. Furthermore, this is one of the first studies to examine the impact of psychosocial stressors on quantitative measures of subjective cognitive status, mood, and sleep. We found worse than average NeuroQoL scores occurred in ∼30% of subjects without COVID-19 across a range of domains. We further demonstrated that financial and social stressors, which may be exacerbated by the pandemic, predict worse NeuroQoL outcomes independent of COVID-19 status. However, a history of COVID-19, and particularly prolonged COVID-19, was associated with significantly worse subjective cognitive dysfunction scores, even after adjusting for baseline differences in demographics, past medical history and stressors. Indeed, most of the abnormalities in NeuroQoL metrics were driven by the subgroup of COVID-19 patients with protracted symptoms. Though there was an association of COVID-19 status with subjective cognitive dysfunction, other socio-demographic factors, including younger age, female gender, history of depression, social isolation and relationship problems with members of the household, were much stronger predictors of worse NeuroQoL metrics.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>27298</offset><text>The relationship between stressors, heightened inflammatory response, mood disorders, cognitive abnormalities and neurodegenerative disease has been well established. Indeed, elevated IL-6 levels, which correlate with COVID-19 severity, have been associated with depression and alterations in activity in the subgenual cingulate cortex. Other symptoms, including fatigue, malaise, myalgias, and joint pain, commonly referred to as “sickness behavior”, are thought to be triggered by proinflammatory cytokines (IL-1α, IL-1β, IL-6, and TNFα) generated as an innate immune response. The inflammatory response generated by pandemic-related stressors may represent the mechanistic underpinning of debilitating symptoms in patients that did not have COVID-19, though more data is needed to support this hypothesis. Among patients with a history of COVID-19, the inflammatory response or cytokine release syndrome associated with infection may synergize with a stressor-related inflammatory response to amplify and prolong post-viral symptoms.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>28346</offset><text>Prolonged COVID-19 symptoms occurred in 25% of participants and were disabling, lasted months following diagnosis, and interfered with work and household responsibilities. The most common protracted symptoms reported in our study were anxiety, headache, “brain fog,” and fatigue, which have also been observed in other cohorts. During the timeframe of this survey there were 26,779,193 United States confirmed COVID-19 cases, representing 8.1% of the total United States population. Our study detected a 7.6% COVID-19 positivity rate, which closely approximates population-based prevalences. Extrapolating from the 25% rate of prolonged symptoms among COVID-19 subjects in our study, there could be as many as 6,694,798 people in the United States currently experiencing post-acute sequelae of COVID-19 or “long-hauler” syndrome. Other countries have also documented prolonged symptoms following SARS-CoV-2 infection. A study conducted in the United Kingdom identified higher rates of stroke, dementia, mood and anxiety disorders 6-months after COVID-19 diagnosis compared to contemporaneous patients diagnosed with a different respiratory tract infections. Similarly, a Chinese study found that 6-months after hospital discharge for COVID-19, 63% of patients had fatigue or muscle weakness, 26% had sleep abnormalities and 23% had anxiety or depression.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>29709</offset><text>While we initially hypothesized that NeuroQoL metrics would be worse among older respondents, in fact, we detected the opposite. Older participants had fewer post-COVID symptoms and were less likely to have limitations in their activities due to symptoms. Older participants also reported fewer stressors. It is possible that the synergistic relationship between viral and stressor-related inflammatory responses was more pronounced in younger respondents. Financial insecurity and unemployment issues were significantly more common in those with prolonged COVID symptoms and these stressors were also inversely correlated with age, perhaps because younger people are less established in their careers, or have less savings. We did, however, detect the suggestion of a bimodal peak, where NeuroQoL scores for depression, sleep and subjective cognitive function appeared to worsen around ages 60–65. The underlying mechanisms related to abnormal scores in these different age ranges may differ and further evaluation is merited.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>30739</offset><text>Limitations of this study include the fact that people who complete online surveys may not be representative of the general United States population in unmeasurable ways. This may limit generalizability to the United States population as a whole. However, our respondent population did closely approximate easily measured United States demographic data, though Hispanics were underrepresented. Second, it is possible we underestimated the prevalence of prolonged COVID symptoms since some of the respondents may have been diagnosed with COVID close to the time of the survey and hence not accrued enough time to qualify for prolonged COVID symptoms. Though the median time from COVID diagnosis to the survey was not statistically different between patients with or without prolonged symptoms, the median time interval was twice as long for those with prolonged symptoms compared to those without (4 versus 2 months). Third, cognitive function and financial stressors may be even worse than we measured, since the ability to complete an online survey requires access to technology and computer competence. Despite this, 29% of respondents reported unemployment, financial insecurity, food insecurity, or homelessness within the month prior to completing the survey, indicating that this was not a rarified group of respondents. Fourth, patients hospitalized with more severe COVID-19 may have substantially different outcomes than this cohort of non-hospitalized community dwellers. Fifth, the number of patients with COVID-19 was relatively small, as was the number of respondents with prolonged-COVID symptoms. However, we powered our survey for an even smaller positivity rate and our data provides important epidemiological information regarding the prevalence of post-acute COVID symptoms. Sixth, because this was a survey we had to rely on self-reported COVID status. Methodologically, obtaining laboratory proof of SARS-CoV-2 infection from all respondents would not have been feasible and our definition of COVID status was the only pragmatic option to obtain data rapidly on a large scale during a pandemic. Because respondents with symptom-based diagnoses tended to be from urban areas, the Northeast and had COVID earlier in the pandemic, it is possible that this group represents the first wave in the New York City area before testing was widely available. Last, NeuroQoL metrics are subjective measures of self-reported health. Objective measures of cognitive dysfunction using formal neuropsychological testing are needed to identify domains of dysfunction, which would guide therapeutic intervention.</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">title_1</infon><offset>33355</offset><text>Conclusion</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>33366</offset><text>Prolonged symptoms lasting a medina of 4 months occurred in 25% of COVID-19 positive participants. NeuroQoL cognitive dysfunction scores were significantly worse among COVID-19 positive subjects, even after accounting for demographic and stressor covariates. Fatigue, anxiety, depression, and sleep scores did not differ between COVID-19 positive and negative respondents. Major factors associated with worse NeuroQoL metrics across a variety of domains were younger age, female gender, history of depression, social isolation, and relationship problems with members of the household.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title_1</infon><offset>33951</offset><text>Data Availability Statement</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>33979</offset><text>The data will be made available to investigators upon reasonable request to the corresponding author.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title_1</infon><offset>34081</offset><text>Ethics Statement</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>34098</offset><text>The studies involving human participants were reviewed and approved by NYU IRB. Written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements.</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">title_1</infon><offset>34333</offset><text>Author Contributions</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">paragraph</infon><offset>34354</offset><text>JF designed the study, analyzed the data, and drafted the manuscript. AL, KM, JL, DK, RH, SY, SM, TW, LB, and SG contributed to the conceptual design of the study, data interpretation, and critical revision of the manuscript. All authors approved the submitted version of the manuscript.</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">title_1</infon><offset>34642</offset><text>Conflict of Interest</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">paragraph</infon><offset>34663</offset><text>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">footnote</infon><offset>34836</offset><text>https://www.prolific.co</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title_1</infon><offset>34860</offset><text>Supplementary Material</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>34883</offset><text>The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fnagi.2021.690383/full#supplementary-material</text></passage><passage><infon key="section_type">REF</infon><infon key="type">title</infon><offset>35042</offset><text>References</text></passage><passage><infon key="comment">Online ahead of print</infon><infon key="name_0">surname:Al-Aly;given-names:Z.</infon><infon key="name_1">surname:Xie;given-names:Y.</infon><infon key="name_2">surname:Bowe;given-names:B.</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="year">2021</infon><offset>35053</offset><text>High-dimensional characterization of post-acute sequalae of COVID-19.</text></passage><passage><infon key="fpage">2283</infon><infon key="lpage">2285</infon><infon key="name_0">surname:Aziz;given-names:M.</infon><infon key="name_1">surname:Fatima;given-names:R.</infon><infon key="name_2">surname:Assaly;given-names:R.</infon><infon key="pub-id_doi">10.1002/jmv.25948</infon><infon key="pub-id_pmid">32343429</infon><infon key="section_type">REF</infon><infon key="source">J. Med. Virol.</infon><infon key="type">ref</infon><infon key="volume">92</infon><infon key="year">2020</infon><offset>35123</offset><text>Elevated interleukin-6 and severe COVID-19: a meta-analysis.</text></passage><passage><infon key="fpage">603</infon><infon key="lpage">605</infon><infon key="name_0">surname:Carfi;given-names:A.</infon><infon key="name_1">surname:Bernabei;given-names:R.</infon><infon key="name_2">surname:Landi;given-names:F.</infon><infon key="pub-id_doi">10.1001/jama.2020.12603</infon><infon key="pub-id_pmid">32644129</infon><infon key="section_type">REF</infon><infon key="source">JAMA</infon><infon key="type">ref</infon><infon key="volume">324</infon><infon key="year">2020</infon><offset>35184</offset><text>Gemelli against C-P-ACSG. persistent symptoms in patients after acute COVID-19.</text></passage><passage><infon key="section_type">REF</infon><infon key="source">Post-COVID Conditions.</infon><infon key="type">ref</infon><infon key="year">2019</infon><offset>35264</offset></passage><passage><infon key="fpage">1860</infon><infon key="lpage">1867</infon><infon key="name_0">surname:Cella;given-names:D.</infon><infon key="name_1">surname:Lai;given-names:J. S.</infon><infon key="name_2">surname:Nowinski;given-names:C. J.</infon><infon key="name_3">surname:Victorson;given-names:D.</infon><infon key="name_4">surname:Peterman;given-names:A.</infon><infon key="name_5">surname:Miller;given-names:D.</infon><infon key="pub-id_doi">10.1212/wnl.0b013e318258f744</infon><infon key="pub-id_pmid">22573626</infon><infon key="section_type">REF</infon><infon key="source">Neurology</infon><infon key="type">ref</infon><infon key="volume">78</infon><infon key="year">2012</infon><offset>35265</offset><text>Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology.</text></passage><passage><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="year">2019</infon><offset>35361</offset></passage><passage><infon key="fpage">945</infon><infon key="lpage">953</infon><infon key="name_0">surname:Cunningham;given-names:C.</infon><infon key="pub-id_doi">10.1042/bst0390945</infon><infon key="pub-id_pmid">21787328</infon><infon key="section_type">REF</infon><infon key="source">Biochem. Soc. Trans.</infon><infon key="type">ref</infon><infon key="volume">39</infon><infon key="year">2011</infon><offset>35362</offset><text>Systemic inflammation and delirium: important co-factors in the progression of dementia.</text></passage><passage><infon key="fpage">2251</infon><infon key="lpage">2252</infon><infon key="name_0">surname:Datta;given-names:S. D.</infon><infon key="name_1">surname:Talwar;given-names:A.</infon><infon key="name_2">surname:Lee;given-names:J. T.</infon><infon key="pub-id_doi">10.1001/jama.2020.22717</infon><infon key="pub-id_pmid">33206133</infon><infon key="section_type">REF</infon><infon key="source">JAMA</infon><infon key="type">ref</infon><infon key="volume">324</infon><infon key="year">2020</infon><offset>35451</offset><text>A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: illness beyond acute infection and public health implications.</text></passage><passage><infon key="fpage">663</infon><infon key="lpage">681</infon><infon key="name_0">surname:Drevets;given-names:W. C.</infon><infon key="name_1">surname:Savitz;given-names:J.</infon><infon key="name_2">surname:Trimble;given-names:M.</infon><infon key="pub-id_doi">10.1017/s1092852900013754</infon><infon key="pub-id_pmid">18704022</infon><infon key="section_type">REF</infon><infon key="source">CNS Spectr.</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">2008</infon><offset>35604</offset><text>The subgenual anterior cingulate cortex in mood disorders.</text></passage><passage><infon key="fpage">e575</infon><infon key="lpage">e586</infon><infon key="name_0">surname:Frontera;given-names:J. A.</infon><infon key="name_1">surname:Sabadia;given-names:S.</infon><infon key="name_2">surname:Lalchan;given-names:R.</infon><infon key="name_3">surname:Fang;given-names:T.</infon><infon key="name_4">surname:Flusty;given-names:B.</infon><infon key="name_5">surname:Millar-Vernetti;given-names:P.</infon><infon key="pub-id_pmid">33020166</infon><infon key="section_type">REF</infon><infon key="source">Neurology</infon><infon key="type">ref</infon><infon key="volume">96</infon><infon key="year">2021</infon><offset>35663</offset><text>A prospective study of neurologic disorders in hospitalized patients with COVID-19 in New York City.</text></passage><passage><infon key="fpage">e1211</infon><infon key="lpage">e1217</infon><infon key="name_0">surname:Frontera;given-names:J. A.</infon><infon key="name_1">surname:Valdes;given-names:E.</infon><infon key="name_2">surname:Huang;given-names:J.</infon><infon key="name_3">surname:Lewis;given-names:A.</infon><infon key="name_4">surname:Lord;given-names:A. S.</infon><infon key="name_5">surname:Zhou;given-names:T.</infon><infon key="pub-id_pmid">32826430</infon><infon key="section_type">REF</infon><infon key="source">Crit. Care Med.</infon><infon key="type">ref</infon><infon key="volume">48</infon><infon key="year">2020</infon><offset>35764</offset><text>Prevalence and impact of hyponatremia in patients with Coronavirus disease in New York City.</text></passage><passage><infon key="fpage">475</infon><infon key="lpage">486</infon><infon key="name_0">surname:Gershon;given-names:R. C.</infon><infon key="name_1">surname:Lai;given-names:J. S.</infon><infon key="name_2">surname:Bode;given-names:R.</infon><infon key="name_3">surname:Choi;given-names:S.</infon><infon key="name_4">surname:Moy;given-names:C.</infon><infon key="name_5">surname:Bleck;given-names:T.</infon><infon key="pub-id_doi">10.1007/s11136-011-9958-8</infon><infon key="pub-id_pmid">21874314</infon><infon key="section_type">REF</infon><infon key="source">Qual. Life Res.</infon><infon key="type">ref</infon><infon key="volume">21</infon><infon key="year">2012</infon><offset>35857</offset><text>Neuro-QOL: quality of life item banks for adults with neurological disorders: item development and calibrations based upon clinical and general population testing.</text></passage><passage><infon key="fpage">407</infon><infon key="lpage">414</infon><infon key="name_0">surname:Harrison;given-names:N. A.</infon><infon key="name_1">surname:Brydon;given-names:L.</infon><infon key="name_2">surname:Walker;given-names:C.</infon><infon key="name_3">surname:Gray;given-names:M. A.</infon><infon key="name_4">surname:Steptoe;given-names:A.</infon><infon key="name_5">surname:Critchley;given-names:H. D.</infon><infon key="pub-id_doi">10.1016/j.biopsych.2009.03.015</infon><infon key="pub-id_pmid">19423079</infon><infon key="section_type">REF</infon><infon key="source">Biol. Psychiatry</infon><infon key="type">ref</infon><infon key="volume">66</infon><infon key="year">2009</infon><offset>36021</offset><text>Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity.</text></passage><passage><infon key="fpage">220</infon><infon key="lpage">232</infon><infon key="name_0">surname:Huang;given-names:C.</infon><infon key="name_1">surname:Huang;given-names:L.</infon><infon key="name_2">surname:Wang;given-names:Y.</infon><infon key="name_3">surname:Li;given-names:X.</infon><infon key="name_4">surname:Ren;given-names:L.</infon><infon key="name_5">surname:Gu;given-names:X.</infon><infon key="pub-id_pmid">33428867</infon><infon key="section_type">REF</infon><infon key="source">Lancet</infon><infon key="type">ref</infon><infon key="volume">397</infon><infon key="year">2021</infon><offset>36135</offset><text>6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.</text></passage><passage><infon key="fpage">535</infon><infon key="lpage">562</infon><infon key="name_0">surname:Jack;given-names:C. R.;suffix:Jr.</infon><infon key="name_1">surname:Bennett;given-names:D. A.</infon><infon key="name_2">surname:Blennow;given-names:K.</infon><infon key="name_3">surname:Carrillo;given-names:M. C.</infon><infon key="name_4">surname:Dunn;given-names:B.</infon><infon key="name_5">surname:Haeberlein;given-names:S. B.</infon><infon key="pub-id_doi">10.1016/j.jalz.2018.02.018</infon><infon key="pub-id_pmid">29653606</infon><infon key="section_type">REF</infon><infon key="source">Alzheimers Dement</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="year">2018</infon><offset>36222</offset><text>NIA-AA research framework: toward a biological definition of Alzheimer’s disease.</text></passage><passage><infon key="issue">e60</infon><infon key="name_0">surname:Jones;given-names:B. D. M.</infon><infon key="name_1">surname:Daskalakis;given-names:Z. J.</infon><infon key="name_2">surname:Carvalho;given-names:A. F.</infon><infon key="name_3">surname:Strawbridge;given-names:R.</infon><infon key="name_4">surname:Young;given-names:A. H.</infon><infon key="name_5">surname:Mulsant;given-names:B. H.</infon><infon key="section_type">REF</infon><infon key="source">BJPsych Open</infon><infon key="type">ref</infon><infon key="volume">6</infon><infon key="year">2020</infon><offset>36306</offset><text>Inflammation as a treatment target in mood disorders: review.</text></passage><passage><infon key="fpage">764</infon><infon key="lpage">772</infon><infon key="name_0">surname:Kondziella;given-names:D.</infon><infon key="name_1">surname:Olsen;given-names:M. H.</infon><infon key="name_2">surname:Dreier;given-names:J. P.</infon><infon key="pub-id_doi">10.1111/ene.14150</infon><infon key="pub-id_pmid">31999855</infon><infon key="section_type">REF</infon><infon key="source">Eur. J. Neurol.</infon><infon key="type">ref</infon><infon key="volume">27</infon><infon key="year">2020</infon><offset>36368</offset><text>Prevalence of visual snow syndrome in the UK.</text></passage><passage><infon key="fpage">1233</infon><infon key="lpage">1244</infon><infon key="name_0">surname:Leisman;given-names:D. E.</infon><infon key="name_1">surname:Ronner;given-names:L.</infon><infon key="name_2">surname:Pinotti;given-names:R.</infon><infon key="name_3">surname:Taylor;given-names:M. D.</infon><infon key="name_4">surname:Sinha;given-names:P.</infon><infon key="name_5">surname:Calfee;given-names:C. S.</infon><infon key="pub-id_doi">10.1016/s2213-2600(20)30404-5</infon><infon key="pub-id_pmid">33075298</infon><infon key="section_type">REF</infon><infon key="source">Lancet Respir. Med.</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">2020</infon><offset>36414</offset><text>Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes.</text></passage><passage><infon key="comment">Online ahead of print</infon><infon key="name_0">surname:Lerner;given-names:A. M.</infon><infon key="name_1">surname:Robinson;given-names:D. A.</infon><infon key="name_2">surname:Yang;given-names:L.</infon><infon key="name_3">surname:Williams;given-names:C. F.</infon><infon key="name_4">surname:Newman;given-names:L. M.</infon><infon key="name_5">surname:Breen;given-names:J. J.</infon><infon key="section_type">REF</infon><infon key="source">Ann. Intern. Med.</infon><infon key="type">ref</infon><infon key="year">2021</infon><offset>36558</offset><text>Toward understanding COVID-19 recovery: national institutes of health workshop on postacute COVID-19.</text></passage><passage><infon key="issue">e0249644</infon><infon key="name_0">surname:Mahmud;given-names:R.</infon><infon key="name_1">surname:Rahman;given-names:M. M.</infon><infon key="name_2">surname:Rassel;given-names:M. A.</infon><infon key="name_3">surname:Monayem;given-names:F. B.</infon><infon key="name_4">surname:Sayeed;given-names:S. K. J. B.</infon><infon key="name_5">surname:Islam;given-names:M. S.</infon><infon key="pub-id_doi">10.1371/journal.pone.0249644</infon><infon key="pub-id_pmid">33831043</infon><infon key="section_type">REF</infon><infon key="source">PLoS One</infon><infon key="type">ref</infon><infon key="volume">16</infon><infon key="year">2021</infon><offset>36660</offset><text>Post-COVID-19 syndrome among symptomatic COVID-19 patients: a prospective cohort study in a tertiary care center of Bangladesh.</text></passage><passage><infon key="issue">50</infon><infon key="name_0">surname:Murray;given-names:C. L.</infon><infon key="name_1">surname:Skelly;given-names:D. T.</infon><infon key="name_2">surname:Cunningham;given-names:C.</infon><infon key="pub-id_doi">10.1186/1742-2094-8-50</infon><infon key="pub-id_pmid">21586125</infon><infon key="section_type">REF</infon><infon key="source">J. Neuroinflamm.</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">2011</infon><offset>36788</offset><text>Exacerbation of CNS inflammation and neurodegeneration by systemic LPS treatment is independent of circulating IL-1beta and IL-6.</text></passage><passage><infon key="fpage">603</infon><infon key="lpage">616.e3</infon><infon key="name_0">surname:Murray;given-names:C.</infon><infon key="name_1">surname:Sanderson;given-names:D. J.</infon><infon key="name_2">surname:Barkus;given-names:C.</infon><infon key="name_3">surname:Deacon;given-names:R. M.</infon><infon key="name_4">surname:Rawlins;given-names:J. N.</infon><infon key="name_5">surname:Bannerman;given-names:D. M.</infon><infon key="pub-id_pmid">20471138</infon><infon key="section_type">REF</infon><infon key="source">Neurobiol. Aging</infon><infon key="type">ref</infon><infon key="volume">33</infon><infon key="year">2012</infon><offset>36918</offset><text>Systemic inflammation induces acute working memory deficits in the primed brain: relevance for delirium.</text></passage><passage><infon key="fpage">601</infon><infon key="lpage">615</infon><infon key="name_0">surname:Nalbandian;given-names:A.</infon><infon key="name_1">surname:Sehgal;given-names:K.</infon><infon key="name_2">surname:Gupta;given-names:A.</infon><infon key="name_3">surname:Madhavan;given-names:M. V.</infon><infon key="name_4">surname:McGroder;given-names:C.</infon><infon key="name_5">surname:Stevens;given-names:J. S.</infon><infon key="pub-id_pmid">33753937</infon><infon key="section_type">REF</infon><infon key="source">Nat. Med.</infon><infon key="type">ref</infon><infon key="volume">27</infon><infon key="year">2021</infon><offset>37023</offset><text>Post-acute COVID-19 syndrome.</text></passage><passage><infon key="fpage">270</infon><infon key="lpage">276</infon><infon key="name_0">surname:Nation;given-names:D. A.</infon><infon key="name_1">surname:Sweeney;given-names:M. D.</infon><infon key="name_2">surname:Montagne;given-names:A.</infon><infon key="name_3">surname:Sagare;given-names:A. P.</infon><infon key="name_4">surname:D’Orazio;given-names:L. M.</infon><infon key="name_5">surname:Pachicano;given-names:M.</infon><infon key="pub-id_doi">10.1038/s41591-018-0297-y</infon><infon key="pub-id_pmid">30643288</infon><infon key="section_type">REF</infon><infon key="source">Nat. Med.</infon><infon key="type">ref</infon><infon key="volume">25</infon><infon key="year">2019</infon><offset>37053</offset><text>Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction.</text></passage><passage><infon key="section_type">REF</infon><infon key="source">Neuro-QoL Health Measures.</infon><infon key="type">ref</infon><offset>37137</offset></passage><passage><infon key="comment">(accessed March 4, 2021)</infon><infon key="section_type">REF</infon><infon key="source">Neuro-QoL Reference Populations.</infon><infon key="type">ref</infon><infon key="year">2021</infon><offset>37138</offset></passage><passage><infon key="comment">(accessed Mar 12, 2015)</infon><infon key="section_type">REF</infon><infon key="source">Neuro-QOL User Manual.</infon><infon key="type">ref</infon><infon key="year">2015</infon><offset>37139</offset></passage><passage><infon key="fpage">92</infon><infon key="lpage">98</infon><infon key="name_0">surname:Pairo-Castineira;given-names:E.</infon><infon key="name_1">surname:Clohisey;given-names:S.</infon><infon key="name_2">surname:Klaric;given-names:L.</infon><infon key="name_3">surname:Bretherick;given-names:A. D.</infon><infon key="name_4">surname:Rawlik;given-names:K.</infon><infon key="name_5">surname:Pasko;given-names:D.</infon><infon key="pub-id_pmid">33307546</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">591</infon><infon key="year">2021</infon><offset>37140</offset><text>Genetic mechanisms of critical illness in COVID-19.</text></passage><passage><infon key="issue">7</infon><infon key="name_0">surname:Parnetti;given-names:L.</infon><infon key="name_1">surname:Chipi;given-names:E.</infon><infon key="name_2">surname:Salvadori;given-names:N.</infon><infon key="name_3">surname:D’Andrea;given-names:K.</infon><infon key="name_4">surname:Eusebi;given-names:P.</infon><infon key="section_type">REF</infon><infon key="source">Alzheimers Res. Ther.</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">2019</infon><offset>37192</offset><text>Prevalence and risk of progression of preclinical Alzheimer’s disease stages: a systematic review and meta-analysis.</text></passage><passage><infon key="fpage">153</infon><infon key="lpage">163</infon><infon key="name_0">surname:Peer;given-names:E.</infon><infon key="name_1">surname:Brandimarte;given-names:L.</infon><infon key="name_2">surname:Samat;given-names:S.</infon><infon key="name_3">surname:Acquisti;given-names:A.</infon><infon key="pub-id_doi">10.1016/j.jesp.2017.01.006</infon><infon key="section_type">REF</infon><infon key="source">J. Exp. Soc. Psychol.</infon><infon key="type">ref</infon><infon key="volume">70</infon><infon key="year">2017</infon><offset>37311</offset><text>Beyond the turk: alternative platforms for crowdsourcing behavioral research.</text></passage><passage><infon key="fpage">158</infon><infon key="lpage">167</infon><infon key="name_0">surname:Sweeney;given-names:M. D.</infon><infon key="name_1">surname:Montagne;given-names:A.</infon><infon key="name_2">surname:Sagare;given-names:A. P.</infon><infon key="name_3">surname:Nation;given-names:D. A.</infon><infon key="name_4">surname:Schneider;given-names:L. S.</infon><infon key="name_5">surname:Chui;given-names:H. C.</infon><infon key="pub-id_pmid">30642436</infon><infon key="section_type">REF</infon><infon key="source">Alzheimers Dement</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="year">2019</infon><offset>37389</offset><text>Vascular dysfunction-The disregarded partner of Alzheimer’s disease.</text></passage><passage><infon key="fpage">416</infon><infon key="lpage">427</infon><infon key="name_0">surname:Taquet;given-names:M.</infon><infon key="name_1">surname:Geddes;given-names:J. R.</infon><infon key="name_2">surname:Husain;given-names:M.</infon><infon key="name_3">surname:Luciano;given-names:S.</infon><infon key="name_4">surname:Harrison;given-names:P. J.</infon><infon key="pub-id_doi">10.1016/s2215-0366(21)00084-5</infon><infon key="pub-id_pmid">33836148</infon><infon key="section_type">REF</infon><infon key="source">Lancet Psychiatry</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">2021</infon><offset>37460</offset><text>6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records.</text></passage><passage><infon key="fpage">993</infon><infon key="lpage">998</infon><infon key="name_0">surname:Tenforde;given-names:M. W.</infon><infon key="name_1">surname:Kim;given-names:S. S.</infon><infon key="name_2">surname:Lindsell;given-names:C. J.</infon><infon key="name_3">surname:Billig Rose;given-names:E.</infon><infon key="name_4">surname:Shapiro;given-names:N. I.</infon><infon key="name_5">surname:Files;given-names:D. C.</infon><infon key="pub-id_doi">10.15585/mmwr.mm6930e1</infon><infon key="pub-id_pmid">32730238</infon><infon key="section_type">REF</infon><infon key="source">MMWR Morb. Mortal Wkly Rep.</infon><infon key="type">ref</infon><infon key="volume">69</infon><infon key="year">2020</infon><offset>37602</offset><text>Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network - united states, March-June.</text></passage><passage><infon key="fpage">674</infon><infon key="lpage">679</infon><infon key="name_0">surname:Tenforde;given-names:M. W.</infon><infon key="name_1">surname:Olson;given-names:S. M.</infon><infon key="name_2">surname:Self;given-names:W. H.</infon><infon key="name_3">surname:Talbot;given-names:H. K.</infon><infon key="name_4">surname:Lindsell;given-names:C. J.</infon><infon key="name_5">surname:Steingrub;given-names:J. S.</infon><infon key="section_type">REF</infon><infon key="source">MMWR Morb. Mortal. Wkly. Rep.</infon><infon key="type">ref</infon><infon key="volume">2021</infon><infon key="year">2021</infon><offset>37776</offset><text>Effectiveness of Pfizer-BioNTech and moderna vaccines against COVID-19 among hospitalized adults aged &gt;/=65 Years - United States. January-March.</text></passage><passage><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="year">2021</infon><offset>37922</offset></passage><passage><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="year">2021</infon><offset>37923</offset></passage><passage><infon key="comment">(accessed February 5, 2021)</infon><infon key="section_type">REF</infon><infon key="source">Confirmed Cases.</infon><infon key="type">ref</infon><infon key="year">2021</infon><offset>37924</offset></passage><passage><infon key="fpage">7</infon><infon key="lpage">51</infon><infon key="name_0">surname:Watt;given-names:D. F.</infon><infon key="name_1">surname:Panksepp;given-names:J.</infon><infon key="pub-id_doi">10.1080/15294145.2009.10773593</infon><infon key="section_type">REF</infon><infon key="source">Neuropsychoanalysis</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">2009</infon><offset>37925</offset><text>Depression: an evolutionarily conserved mechanism to terminate separation distress? A review of aminergic, peptidergic, and neural network perspectives.</text></passage><passage><infon key="section_type">REF</infon><infon key="source">Global COVID-19 Clinical Platform Case Report Form (CRF) for Post COVID Condition (Post COVID-19 CRF).</infon><infon key="type">ref</infon><infon key="year">2021</infon><offset>38078</offset></passage><passage><infon key="fpage">35</infon><infon key="lpage">37</infon><infon key="name_0">surname:Zhu;given-names:J.</infon><infon key="name_1">surname:Pang;given-names:J.</infon><infon key="name_2">surname:Ji;given-names:P.</infon><infon key="name_3">surname:Zhong;given-names:Z.</infon><infon key="name_4">surname:Li;given-names:H.</infon><infon key="name_5">surname:Li;given-names:B.</infon><infon key="pub-id_doi">10.1002/jmv.26085</infon><infon key="pub-id_pmid">32470146</infon><infon key="section_type">REF</infon><infon key="source">J. Med. Virol.</infon><infon key="type">ref</infon><infon key="volume">93</infon><infon key="year">2021</infon><offset>38079</offset><text>Elevated interleukin-6 is associated with severity of COVID-19: a meta-analysis.</text></passage></document></collection>
